IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 303 participants.
Also called NCT01226563
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 303 participants
- Sponsor
- Bellerophon BCM LLC
- Registry
-
NCT01226563
-
- Other papers using this trial's data
- Bioabsorbable Intracoronary Matrix for Prevention of Ventricular Remodeling After Myocardial Infarction
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Australia, Belgium, Canada, France, Germany, Israel, Poland, Spain
- Registry status
- Completed
Technical summary
Registry record NCT01226563. Randomized; triple masking; primary purpose prevention. Start 2012-04 (registry gives no type); primary completion 2015-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction
- Acronym
- PRESERVATION-1
- Condition
- Acute Myocardial Infarction
- Condition
- Congestive Heart Failure
- Condition
- ST-Elevation Myocardial Infarction
- Intervention (Device)
- IK-5001
- Intervention (Device)
- Saline Solution
- Lead sponsor
- Bellerophon BCM LLC
Record details
- Record id
cardio:ct-nct01226563- Content hash
b9670f61ab63461be8fd0c00b8c2e427ee671a78f1a87cbc81293a676c07ea22